{'fraction_non_alphanumeric': 0.03076923076923077, 'fraction_numerical': 0.026573426573426574, 'mean_word_length': 5.509090909090909, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Safety of Sublingual Immunotherapy With One or Multiple Pollen Allergens in Children

Agostinis F, Foglia C, Landi M, et al. Allergy. 2008;63(12):1637–1639

PURPOSE OF THE STUDY. To evaluate the rate and type of adverse events experienced by children receiving sublingual immunotherapy (SLIT) for pollen allergy with either single or multiple allergen extracts.

STUDY POPULATION. Prospective postmarketing survey of 433 children receiving SLIT for respiratory allergies attributable to pollen.

METHODS. Consecutive children with respiratory allergies attributable to pollens who were receiving SLIT with multiple or single allergens were enrolled. Parents recorded adverse events (eye symptoms, rhinitis/ear …